21 June 2021 – Waymo Drives $2.5bn Investment

The Big Ones

Waymo, the autonomous driving technology developer spun off by Alphabet, has raised $2.5bn in funding from investors including its former parent company. AutoNation and Magna International also took part in the round, as did group Fidelity Management & Research, Mubadala, Temasek, Andreessen Horowitz, Canada Pension Plan Investment Board, Perry Creek Capital, Silver Lake, Tiger Global Management and funds and accounts advised by T Rowe Price. The company reportedly closed its first external funding round at $3.2bn in July 2020, at a $30bn valuation, having pulled in $750m from investors including Fidelity, Perry Creek Capital and funds and accounts advised by T Rowe Price two months earlier. Alphabet, Magna, AutoNation, Silver Lake, Canada Pension Plan Investment Board, Mubadala Investment Company and Andreessen Horowitz had supplied $2.25bn for Waymo in March the same year.

US-based venture capital firm G2 Venture Partners (G2VP) has closed its Fund II at $500m with commitments from Shell, Mitsui, Daimler and ABB Switzerland. The McKnight Foundation and John Doerr, chairman of VC firm Kleiner Perkins, reportedly also committed to the fund. Shell contributed through its corporate venturing arm, Shell Ventures. It was also a limited partner in G2VP’s inaugural fund, which was sized at $350m. G2VP was founded in 2017 as a spinoff from Kleiner Perkins’ Green Growth fund. It focuses on companies developing emerging technologies that could accelerate sustainable transformation in traditional industries.

Marqeta, a US-based card-issuing platform developer backed by CommerzBank, CreditEase, Visa and Mastercard, has closed its initial public offering at approximately $1.41bn. The company raised an initial $1.22bn in the offering last week, issuing 45.5 million class A shares on the Nasdaq Global Select Market priced at $27 each. Its shares are currently (that’s Friday afternoon UK time) for $29.43 each, and the underwriters have taken up the option to buy more than 6.8 million more shares. The IPO followed over $526m in funding for the company.

This isn’t a crossover (although there actually were several worth more than $100m last week – check our websites for more on those), but this one’s too interesting to skip just because there aren’t any CVCs. Celonis, a Germany-based business process analytics software spinout of Technical University of Munich (TUM), has raised $1bn in a series D round co-led by Durable Capital Partners and funds and accounts advised by T Rowe Price Associates. What makes this one special isn’t so much the size of the round (as impressive as that is, obviously) but that it valued Celonis at $11bn post-money, making it Germany’s first decacorn. Celonis has now raised nearly $1.37bn in funding altogether. The spinout fetched a $2.5bn valuation when it raised $290m in a series C round led by Arena Holdings, and – almost as notable as being the first decacorn in the country – Celonis also became TUM’s first unicorn when it closed a $50m series B round backed by Accel and 83North in June 2018. How’s that for a European success story?

Deals

China-based semiconductor technology developer Horizon Robotics has raised $1.5bn in series C7 funding from electronic parts manufacturer BOE Technology and chipmaker Will Semiconductor. The round was secured at a $5bn valuation, and it came after a $300m series C6 round at an unspecified time that included Legend Capital, Huangpu River Capital and unnamed others.

Byju’s, an India-based online learning portal backed by Bennett Coleman & Co, Naspers and Tencent, has secured Rs 25bn ($340m) in funding. UBS Group, Blackstone, Abu Dhabi government-backed ADQ and Phoenix Rising–Beacon Holdings as well as Eric Yuan all took part in the round. The cash injection is part of a $1.5bn round Byju’s began raising in April this year, sources privy to the matter told the Economic Times, and it valued the company at $16.5bn post-money.

US-based graph technology provider Neo4J received $325m in a series F round featuring GV. Private equity firm Eurazeo led the round at a valuation exceeding $2bn, and DTCP, the investment firm backed by Deutsche Telekom, also took part, as did One Peak, Creandum, Greenbridge Partners and Lightrock. The company was founded in 2007 as Neo Technology and has now raised $515m.

ApplyBoard, the Canada-based international student facilitation service that counts educational services firm Educational Testing Service (ETS) as an investor, has confirmed a C$375m ($308m) series D round. Ontario Teachers’ Pension Plan Board led the round through its Teachers’ Innovation Platform, and it included investment and financial services group Fidelity in addition to BDC, Harmonic Growth Partners, Index Ventures, Garage Capital and Blue Cloud Ventures. The company’s confirmation came in the wake of media reports a week earlier suggesting it had raised $230m in the round, which it said this week valued it at $3.2bn post-money.

Chehaoduo, the China-based automotive e-commerce marketplace backed by SoftBank, Tencent and Shougang, has closed a $300m funding round valuing it at $10bn. H Capital led the round, which also featured Sequoia Capital China, IDG Capital and Chehaoduo founder and CEO Yang Haoyong. The company’s overall equity funding now stands at about $3.8bn. It was spun off by online classified listings operator Ganji in 2015.

Thumbtack, the US-headquartered operator of a home renovation services marketplace, has raised $275m from investors including CapitalG, the growth equity arm of Alphabet. Sovereign wealth fund Qatar Investment Authority led the round, which also featured Blackstone’s Alternative Asset Management subsidiary, G Squared, Baillie Gifford, Founders Circle Capital, Sequoia Capital and Tiger Global Management. The round valued the company at $3.2bn. The latest round boosted the company’s overall funding to $697m.

Yaoshibang, the China-based operator of a supply chain platform for the pharmaceutical industry, has raised $270m in funding from investors including internet group Baidu. Zhejiang Pearl River Investment Management, Green Pine Capital Partners and Guangzhou City Construction Investment’s SF Fund also participated in the round, along with unnamed insurance firms and sovereign wealth funds. It was facilitated by China Renaissance.

Funds

Flagship Pioneering, a US-based biotechnology venture studio that regularly taps into university research to build companies such as Moderna, has raised another $2.23bn for its Fund VII from new and existing limited partners, bringing the vehicle to $3.37bn. It reopened the fund to additional capital in April this year but didn’t identify the LPs. Flagship now has $14.1bn in assets under management and is operating with an aggregate capital pool of $6.7bn. It has launched more than 100 ventures since its founding, with a current portfolio of 41 companies.

Exits

UK-based clean aircraft developer Vertical Aerospace has agreed to a reverse takeover with special purpose acquisition company Broadstone Acquisition Corp that will be backed by American Airlines, Avolon, Honeywell, Rolls-Royce, Standard Industries’ 40 North vehicle and Microsoft’s M12 unit. The merged business will be valued at $2.2bn and will take up the listing on the New York Stock secured by Broadstone through a $300m initial public offering in September 2020.

Kanzhun, a China-based online job portal operator backed by internet group Tencent and insurance firm Sunshine Life, has floated in a $912m initial public offering on the Nasdaq Global Select Market. The company issued 48 million American depositary shares, each representing two ordinary shares, priced at the top of the IPO’s $17 to $19 range. As we’re recording this on Friday afternoon UK time, shares are going for $38.

Monday.com, the US-based software development platform operator that now counts Salesforce and Zoom as investors, has closed its initial public offering at $631m. The corporates each purchased $75m of shares in a private placement alongside the offering, which involved Monday issuing an initial 3.7 million shares on the Nasdaq Global Select Market a week ago priced at $155 each. The underwriters subsequently took up the option to buy another 370,000 shares to close the offering. As we’re recording this on Friday afternoon UK time, shares are priced at $230.96.

Lyell Immunopharma, a US-based immunotherapy developer which counts GlaxoSmithKline (GSK) and Celgene as investors, has raised $425m in its initial public offering. The company issued 25 million shares on the Nasdaq Global Market at a price of $17 each, the mid-point of the offering’s $16 to $18 range. Its shares closed at $16.89 at the end of the first day. Lyell had raised $834m across just three rounds since it was founded in 2018. GSK has walked away with a 12.5% stake post-IPO, while Celgene’s retained 4.5%.

Verve Therapeutics, a US-based cardiovascular disease therapy developer advancing Broad Institute and University of Pennsylvania research, has gone public in a $267m initial public offering representing exits Alphabet and Novo. The offering consists of just over 14 million shares issued on the Nasdaq Global Select Market, increased from 11.8 million and priced at $19.00 each, above the $16 to $18 range set for the offering. The IPO price valued the company at approximately $876m.

Wise, the UK-based operator of a cross-border capital transfer service, plans to launch a direct listing that would give conglomerate Mitsui a chance to sell its shares. The company plans to list on the London Stock Exchange. Formerly known as TransferWise, Wise runs an online platform that allows users to send money internationally without paying exorbitant fees typically associated with international bank transfers. Wise last raised primary funding in 2017 but was valued at $5bn in a $319m secondary share sale in July 2020.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

14 June 2021 – Cambridge Launches Deeptech Labs

The Big Ones

1

There is a lot happening in Cambridge, England. The university might have passed its 800th anniversary earlier in this century but the basics of its operating model to bring the smartest people in the world together to solve its hardest challenges remains intact.

The latest advances include the launch and first cohort for Deeptech Labs (DTL), a new post-seed accelerator aimed at deep technology startups, Honeywell’s quantum computing division’s merger and up to $300m investment in Cambridge Quantum Computing and the potential acquisition of local tech champion Arm by US-based artificial intelligence (AI) chip maker Nvidia following the blow-out flotation of cybersecurity champion Darktrace.

DTL is backed by Arm and the University of Cambridge as well as venture capital firm Cambridge Innovation Capital (CIC, the “unicorn factory” at the heart of the city), its chairman Ewan Kirk (founder of hedge fund Cantab Capital Partners), and local industrial conglomerate Marshall’s corporate angel fund, Martlet Capital.

Its inaugural cohort that runs to a demo day on 18 June it has made investments in five machine learning and data science companies: AutoFill, BKwai, Circuit Mind, Contilio and Mindtech.

Zara Riahi, CEO and co-founder of Contilio, said “We are building the world’s first 3D AI analytics platform used by global construction companies and asset owners. To accelerate the next phase of our growth, we were looking for a scaling partner that understood deeptech and had access to the best advisers, deeptech investors, and global operators. The people who have been in the trenches. We are delighted to have found an amazing one in Deeptech Labs.”

These startups receive £350,000 (about $500,000) and a structured three-month development programme, including mentors from Arm, CSR, Imagination Technologies, Analysis, Active Hotels, Arieso, Blinkx, Cloudamize, Focal Point, Riverlane and Ubisense. Its second cohort will start in September and include a delegation of investors from the GCV Symposium being held on 3-4 November.

Miles Kirby, CEO of DTL, who has also been inventor and holder of more than 30 patents and former founder of Allianz-backed AV8 Ventures as well as European managing director of Qualcomm Ventures, said: “This ambitious, new 13-week seed to series A programme is designed to enable deeptech startups to leverage the best minds in this space.”

Andrew Williamson, the managing partner at CIC, added: “Cambridge is one of the best places in the world to build a deeptech business, with access to best-in-class talents, exceptional intellectual property, and experienced entrepreneurs and investors. Deeptech Labs enables a new generation of entrepreneurs to access this ecosystem. As a cofounder, CIC has been delighted to support Miles and his team in shaping the vision. This is a very high quality first cohort and we look forward to working with them in the future and supporting their growth.”

Adam Bastin, vice-president of corporate development at Arm, said: “From Arm’s earliest days in a barn just outside the city, to its position as a global technology leader headquartered here today, Cambridge has remained a critical hub of talent, creativity and innovation. In co-founding Deeptech Labs, we are pleased to support the next generation of game-changing technology companies by helping them to access the world-class Cambridge technology ecosystem.”

2

Tim Haines, managing partner of Abingworth, a biotech venture-capital firm, in the latest Economist said we were in “the golden age of diagnostics”.

What that really seems to mean it is faster and easier than ever before for groups such as Roche and Merck to test and design treatments using genetics and epigenetics. This is leading to more personalised care rather than blockbuster drugs applicable to the masses.

The model works if the insights derived and results delivered can be more profitable, which likely means targeting rich people’s problems and delivering their longevity escape velocity where their life expectancy increases by more than a year for each year they live.

Severin Schwan, Roche’s seventh CEO in 125 years, in an interview with the Economist talked about the “insights” business as a third pillar for Roche—as big, if not bigger, than diagnostics and pharma.

Beyond the social inequality and impact on social services, it also opens up healthcare to consumer-facing technology companies.

As the Economist noted, Roche’s insights business was effectively formed through its acquisitions of Foundation Medicine, a gene-sequencing company that can identify cancers from DNA in blood samples, and Flatiron Health, a specialist in cancer-related health records that generates data on patients from the real world, supplementing clinical trials. Roche valued Flatiron at $2.15bn in its 2018 purchase and closed out the purchaseof the remaining minority shares in Foundation the same year at a $5.3bn valuation.

Both Foundation and Flatiron were backed by GV, formerly known as Google Ventures and a corporate venturing unit for US-listed Alphabet.

GV has made much of its name and returns over the past decade from a string of life sciences and healthcare deals and exits but Carole Nuechterlein, head of Roche Venture Fund at the drugs group’s headquarters in Switzerland, takes much of the credit for the handling of these deals.

Roche had been shareholder in both Flatiron and Foundation before taking control but leaving much autonomy with both groups.

This is the model Roche followed with its $47bn purchase of Genentech back in 2009. As probably the founding biotech – a then-young VC firm in Kleiner Perkins had its partner Bob Swanson close a seed deal over a beer with lead scientist Herb Boyer – Genentech listed in 1980 before eventually falling to Roche and bringing its blockbuster drugs to the Swiss group for greater distribution and up to $21bn in annual sales a decade later.

Now celebrating 20 years running Roche Ventures, Nuechterlein – a prior GCV Powerlist award winner – has seen it all before.

But never at such scale. It is actually a golden age for healthcare not just diagnostics as the century for biology is now firmly underway.

The next GCV Powerlist will be announced on 21 July thanks to partner Dentons as part of the GCV Digital Forum and my thanks to the Global Healthcare Council for its work on the latest quarterly report out next week.

Fund

Alibaba Cloud floats $1bn investment scheme

Fortune VC smiles on $858m first close

Asset manager Alantra has reached the first close at more than €80m ($97m) for its Klima Energy Transition Fund including commitments from Enagás, a Spain-based gas grid operator.

Uncle Nearest drinks to $50m investment vehicle

Coupa creates $50m corporate venturing fund

Recorded Future, a US-based threat intelligence company previously backed by corporate venturing unit REV Venture Partners over the past six years, has set up a $20m fund for early-stage startups.

Recorded Future’s Intelligence Fund will back seed and series A rounds, with its first deals including SecurityTrails and Gemini Advisory.

United Airlines, a US-based flight operator, has started its corporate venturing unit.
United Airlines Ventures will focus on sustainability concepts that support the company’s goal of net-zero emissions by 2050, as well as other travel-related startups.

Michael Leskinen, United’s vice-president of corporate development and investor relations, will oversee the venture unit as president and incorporate its initial investments in Archer Aviation, Clear and Fulcrum BioEnergy.

Rapyd, a UK-based payments company that earlier in the year closed a $300m round, has set up a corporate venturing unit to invest in early-stage fintech startups.

Rapyd Ventures said its first investment would be in the seed round for Gotrade, a fractional stock trading platform that enables users in over 150 countries to invest in US shares.

Exit

Didi begins IPO proceedings in the US

MissFresh to pay visit to public markets

Monday.com meets Salesforce and Zoom amid $574m IPO

Wallbox opens to $1.5bn reverse merger

1stdibs dives into $115m IPO

Ciox and Datavant converge in $7bn deal

Sinch sets out $1.3bn MessageMedia acquisition

Dave banks on $4bn reverse merger

One Medical eyes $2.1bn Iora acquisition

Marqeta gets to market in $1.2bn IPO

Dingdong Maicai bids for public markets spot

Clear makes space for initial public offering

Babylon agrees $4.2bn reverse merger

Xometry looks to assemble IPO
CVRx looks to pump $75m out of IPO

University

Metacon makes Helbio its own

Deals

Northvolt plugs into $2.75bn

Nubank cashes $750m in series G extension

Klarna claws in $639m

Chubby Bear gets its paws on $400m

Investors entrust Trulioo with $394m

Ledger leaps to $380m series C

Hesai gets handed $300m

ApplyBoard recruits investors for $230m round

Dingdang gets $220m funding delivery

Eightfold AI employs SoftBank for $220m series E

Scalable Capital secures $183m

Monogram Health identifies Humana for $160m round

Verbit eyes public listing amid $157m series D

LetsGetChecked executes $150m series D

Lilly helps inject $108m into Synthekine

MatchMove meets $100m funding

Embroker embraces $100m series C

EcoFlow stores $100m in series B round


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0